Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-18

Clinical Trial Update: A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating pharmacokinetics of nusinersen when delivered through the ThecaFlex DRx system in adults and pediatric participants with spi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinraza (nusinersen)

Snippet

Sponsor: Biogen | Conditions: Muscular Atrophy, Spinal | Phase 1 | Status: RECRUITING